![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PSMC4 |
Gene summary for PSMC4 |
![]() |
Gene information | Species | Human | Gene symbol | PSMC4 | Gene ID | 5704 |
Gene name | proteasome 26S subunit, ATPase 4 | |
Gene Alias | MIP224 | |
Cytomap | 19q13.2 | |
Gene Type | protein-coding | GO ID | GO:0001701 | UniProtAcc | A8K2M0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5704 | PSMC4 | CA_HPV_2 | Human | Cervix | CC | 2.45e-05 | 3.03e-01 | 0.0391 |
5704 | PSMC4 | Tumor | Human | Cervix | CC | 4.61e-10 | 3.65e-01 | 0.1241 |
5704 | PSMC4 | sample1 | Human | Cervix | CC | 5.47e-14 | 7.06e-01 | 0.0959 |
5704 | PSMC4 | sample3 | Human | Cervix | CC | 7.68e-08 | 3.11e-01 | 0.1387 |
5704 | PSMC4 | T1 | Human | Cervix | CC | 1.19e-14 | 5.29e-01 | 0.0918 |
5704 | PSMC4 | T3 | Human | Cervix | CC | 3.84e-07 | 2.90e-01 | 0.1389 |
5704 | PSMC4 | HTA11_2487_2000001011 | Human | Colorectum | SER | 5.34e-07 | 2.63e-01 | -0.1808 |
5704 | PSMC4 | HTA11_1938_2000001011 | Human | Colorectum | AD | 6.90e-04 | 2.58e-01 | -0.0811 |
5704 | PSMC4 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.50e-09 | 2.59e-01 | -0.1954 |
5704 | PSMC4 | HTA11_411_2000001011 | Human | Colorectum | SER | 4.06e-04 | 5.70e-01 | -0.2602 |
5704 | PSMC4 | HTA11_3361_2000001011 | Human | Colorectum | AD | 9.73e-04 | 2.28e-01 | -0.1207 |
5704 | PSMC4 | HTA11_696_2000001011 | Human | Colorectum | AD | 3.09e-06 | 2.66e-01 | -0.1464 |
5704 | PSMC4 | HTA11_1391_2000001011 | Human | Colorectum | AD | 4.12e-13 | 3.65e-01 | -0.059 |
5704 | PSMC4 | HTA11_866_3004761011 | Human | Colorectum | AD | 4.49e-10 | 2.84e-01 | 0.096 |
5704 | PSMC4 | HTA11_7696_3000711011 | Human | Colorectum | AD | 7.30e-03 | 2.01e-01 | 0.0674 |
5704 | PSMC4 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 3.03e-05 | 1.96e-01 | 0.294 |
5704 | PSMC4 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 3.53e-02 | 7.05e-01 | 0.3487 |
5704 | PSMC4 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 1.50e-05 | 2.48e-01 | 0.281 |
5704 | PSMC4 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.31e-03 | 3.24e-01 | 0.3859 |
5704 | PSMC4 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 3.40e-04 | 3.38e-01 | 0.2585 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004217610 | Cervix | CC | regulation of protein catabolic process | 104/2311 | 391/18723 | 9.39e-15 | 9.36e-12 | 104 |
GO:004586210 | Cervix | CC | positive regulation of proteolysis | 95/2311 | 372/18723 | 1.84e-12 | 6.86e-10 | 95 |
GO:190336210 | Cervix | CC | regulation of cellular protein catabolic process | 72/2311 | 255/18723 | 5.98e-12 | 2.10e-09 | 72 |
GO:004573210 | Cervix | CC | positive regulation of protein catabolic process | 65/2311 | 231/18723 | 7.44e-11 | 1.39e-08 | 65 |
GO:001049810 | Cervix | CC | proteasomal protein catabolic process | 111/2311 | 490/18723 | 8.98e-11 | 1.58e-08 | 111 |
GO:000989610 | Cervix | CC | positive regulation of catabolic process | 109/2311 | 492/18723 | 5.26e-10 | 6.99e-08 | 109 |
GO:190305010 | Cervix | CC | regulation of proteolysis involved in cellular protein catabolic process | 60/2311 | 221/18723 | 1.82e-09 | 1.98e-07 | 60 |
GO:004316110 | Cervix | CC | proteasome-mediated ubiquitin-dependent protein catabolic process | 91/2311 | 412/18723 | 1.65e-08 | 1.25e-06 | 91 |
GO:003133110 | Cervix | CC | positive regulation of cellular catabolic process | 91/2311 | 427/18723 | 9.64e-08 | 5.25e-06 | 91 |
GO:190336410 | Cervix | CC | positive regulation of cellular protein catabolic process | 43/2311 | 155/18723 | 1.80e-07 | 8.28e-06 | 43 |
GO:006113610 | Cervix | CC | regulation of proteasomal protein catabolic process | 48/2311 | 187/18723 | 4.63e-07 | 1.77e-05 | 48 |
GO:19030528 | Cervix | CC | positive regulation of proteolysis involved in cellular protein catabolic process | 34/2311 | 133/18723 | 2.28e-05 | 4.01e-04 | 34 |
GO:00017018 | Cervix | CC | in utero embryonic development | 71/2311 | 367/18723 | 7.21e-05 | 1.00e-03 | 71 |
GO:19018008 | Cervix | CC | positive regulation of proteasomal protein catabolic process | 29/2311 | 114/18723 | 9.71e-05 | 1.27e-03 | 29 |
GO:0042176 | Colorectum | AD | regulation of protein catabolic process | 160/3918 | 391/18723 | 1.06e-19 | 7.34e-17 | 160 |
GO:0009896 | Colorectum | AD | positive regulation of catabolic process | 180/3918 | 492/18723 | 4.33e-16 | 1.94e-13 | 180 |
GO:1903362 | Colorectum | AD | regulation of cellular protein catabolic process | 109/3918 | 255/18723 | 2.14e-15 | 6.08e-13 | 109 |
GO:0010498 | Colorectum | AD | proteasomal protein catabolic process | 174/3918 | 490/18723 | 3.18e-14 | 7.66e-12 | 174 |
GO:0031331 | Colorectum | AD | positive regulation of cellular catabolic process | 156/3918 | 427/18723 | 4.68e-14 | 1.05e-11 | 156 |
GO:1903050 | Colorectum | AD | regulation of proteolysis involved in cellular protein catabolic process | 92/3918 | 221/18723 | 2.04e-12 | 3.19e-10 | 92 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501028 | Oral cavity | OSCC | Alzheimer disease | 244/3704 | 384/8465 | 1.18e-15 | 3.60e-14 | 1.83e-14 | 244 |
hsa0502228 | Oral cavity | OSCC | Pathways of neurodegeneration - multiple diseases | 292/3704 | 476/8465 | 1.60e-15 | 4.47e-14 | 2.28e-14 | 292 |
hsa0502028 | Oral cavity | OSCC | Prion disease | 181/3704 | 273/8465 | 2.05e-14 | 5.30e-13 | 2.70e-13 | 181 |
hsa0305020 | Oral cavity | OSCC | Proteasome | 42/3704 | 46/8465 | 1.32e-11 | 2.01e-10 | 1.02e-10 | 42 |
hsa0501725 | Oral cavity | OSCC | Spinocerebellar ataxia | 86/3704 | 143/8465 | 5.21e-05 | 2.08e-04 | 1.06e-04 | 86 |
hsa05014112 | Oral cavity | OSCC | Amyotrophic lateral sclerosis | 246/3704 | 364/8465 | 6.65e-21 | 1.11e-18 | 5.67e-19 | 246 |
hsa05012113 | Oral cavity | OSCC | Parkinson disease | 188/3704 | 266/8465 | 1.82e-19 | 1.52e-17 | 7.75e-18 | 188 |
hsa05016112 | Oral cavity | OSCC | Huntington disease | 204/3704 | 306/8465 | 1.70e-16 | 7.13e-15 | 3.63e-15 | 204 |
hsa05169113 | Oral cavity | OSCC | Epstein-Barr virus infection | 144/3704 | 202/8465 | 1.08e-15 | 3.60e-14 | 1.83e-14 | 144 |
hsa05010112 | Oral cavity | OSCC | Alzheimer disease | 244/3704 | 384/8465 | 1.18e-15 | 3.60e-14 | 1.83e-14 | 244 |
hsa05022112 | Oral cavity | OSCC | Pathways of neurodegeneration - multiple diseases | 292/3704 | 476/8465 | 1.60e-15 | 4.47e-14 | 2.28e-14 | 292 |
hsa05020112 | Oral cavity | OSCC | Prion disease | 181/3704 | 273/8465 | 2.05e-14 | 5.30e-13 | 2.70e-13 | 181 |
hsa03050110 | Oral cavity | OSCC | Proteasome | 42/3704 | 46/8465 | 1.32e-11 | 2.01e-10 | 1.02e-10 | 42 |
hsa05017111 | Oral cavity | OSCC | Spinocerebellar ataxia | 86/3704 | 143/8465 | 5.21e-05 | 2.08e-04 | 1.06e-04 | 86 |
hsa05012210 | Oral cavity | LP | Parkinson disease | 166/2418 | 266/8465 | 2.02e-31 | 3.36e-29 | 2.17e-29 | 166 |
hsa0501429 | Oral cavity | LP | Amyotrophic lateral sclerosis | 197/2418 | 364/8465 | 1.25e-25 | 1.39e-23 | 8.93e-24 | 197 |
hsa0501629 | Oral cavity | LP | Huntington disease | 172/2418 | 306/8465 | 6.31e-25 | 5.25e-23 | 3.39e-23 | 172 |
hsa0501029 | Oral cavity | LP | Alzheimer disease | 197/2418 | 384/8465 | 6.66e-22 | 3.69e-20 | 2.38e-20 | 197 |
hsa0502229 | Oral cavity | LP | Pathways of neurodegeneration - multiple diseases | 232/2418 | 476/8465 | 7.77e-22 | 3.69e-20 | 2.38e-20 | 232 |
hsa0502029 | Oral cavity | LP | Prion disease | 149/2418 | 273/8465 | 4.88e-20 | 1.81e-18 | 1.16e-18 | 149 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PSMC4 | SNV | Missense_Mutation | c.481N>C | p.Asp161His | p.D161H | P43686 | protein_coding | deleterious(0.01) | possibly_damaging(0.77) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
PSMC4 | SNV | Missense_Mutation | c.565N>A | p.Glu189Lys | p.E189K | P43686 | protein_coding | deleterious(0.02) | benign(0.098) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PSMC4 | SNV | Missense_Mutation | c.383N>T | p.Ala128Val | p.A128V | P43686 | protein_coding | tolerated(0.18) | benign(0.283) | TCGA-B6-A0I8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
PSMC4 | SNV | Missense_Mutation | c.1154T>C | p.Leu385Ser | p.L385S | P43686 | protein_coding | tolerated(0.27) | benign(0.071) | TCGA-D8-A142-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cyclophosphamid | SD | |
PSMC4 | SNV | Missense_Mutation | c.646N>A | p.Ala216Thr | p.A216T | P43686 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-E2-A150-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD | |
PSMC4 | SNV | Missense_Mutation | novel | c.970C>T | p.Pro324Ser | p.P324S | P43686 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-LL-A5YP-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD |
PSMC4 | SNV | Missense_Mutation | c.565N>A | p.Glu189Lys | p.E189K | P43686 | protein_coding | deleterious(0.02) | benign(0.098) | TCGA-AA-3846-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PSMC4 | SNV | Missense_Mutation | c.617N>T | p.Gly206Val | p.G206V | P43686 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-F4-6856-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Ancillary | leucovorin | CR | |
PSMC4 | insertion | Frame_Shift_Ins | rs765768285 | c.598dupC | p.Arg200ProfsTer43 | p.R200Pfs*43 | P43686 | protein_coding | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
PSMC4 | SNV | Missense_Mutation | c.1016G>A | p.Arg339His | p.R339H | P43686 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5704 | PSMC4 | NA | CARFILZOMIB | CARFILZOMIB | 24524217 | |
5704 | PSMC4 | NA | inhibitor | CARFILZOMIB | CARFILZOMIB | |
5704 | PSMC4 | NA | inhibitor | CHEMBL2103884 | OPROZOMIB | |
5704 | PSMC4 | NA | inhibitor | BORTEZOMIB | BORTEZOMIB | |
5704 | PSMC4 | NA | inhibitor | CHEMBL3545432 | IXAZOMIB CITRATE | |
5704 | PSMC4 | NA | BORTEZOMIB | BORTEZOMIB | 24524217 | |
5704 | PSMC4 | NA | inhibitor | CHEMBL451887 | CARFILZOMIB | |
5704 | PSMC4 | NA | inhibitor | CHEMBL325041 | BORTEZOMIB |
Page: 1 |